Guidelines for diagnosis of therapeutic drug-induced liver injury in liver biopsies.
D045930:Anabolic Agents / Q000009:adverse effects; D001706:Biopsy; D002400:Cathartics / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000473:pathology; D002746:Chlorpromazine / Q000009:adverse effects; D002779:Cholestasis / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D003276:Contraceptives, Oral / Q000009:adverse effects; D004295:Dihydroxyphenylalanine / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006221:Halothane / Q000009:adverse effects; D006801:Humans; D007211:Indoles / Q000009:adverse effects; D008099:Liver / Q000473:pathology*; D010636:Phenols / Q000009:adverse effects
D045930:Anabolic Agents; D002400:Cathartics; D003276:Contraceptives, Oral; D007211:Indoles; D010636:Phenols; D004295:Dihydroxyphenylalanine; D002746:Chlorpromazine; D006221:Halothane